PharmaShots | Incisive News in 3 Shots

Subscribe Now

EGFR-Mutated Lung Cancer

AstraZeneca's Tagrisso (osimertinib) Receives EU's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer

AstraZeneca's Tagrisso (osimertinib) Receives EU's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated L...

May 28, 2021

AstraZeneca's Tagrisso (osimertinib) Receives the US FDA's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer

AstraZeneca's Tagrisso (osimertinib) Receives the US FDA's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-M...

December 22, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us